Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to A Latest intelligence report published by Market IntelliX, the global market for Solid Dosage Form Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Solid Dosage Form Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Tablet segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Solid Dosage Form Drug include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report aims to provide a comprehensive study of the global market for Solid Dosage Form Drug. Report Highlights:
(1) Global Solid Dosage Form Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Solid Dosage Form Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Solid Dosage Form Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Solid Dosage Form Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Solid Dosage Form Drug segment by type and by application and regional segment by type and by application.
(6) Solid Dosage Form Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Tablet
Capsules
Other
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Teva
Boehringer Ingelheim
Biogen
Astellas
1 Market Overview
1.1 Product Overview and Scope of Solid Dosage Form Drug
1.2 Global Solid Dosage Form Drug Market Size and Forecast
1.3 China Solid Dosage Form Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Solid Dosage Form Drug Share in Global Market, 2018-2029
1.4.2 Solid Dosage Form Drug Market Size: China VS Global, 2018-2029
1.5 Solid Dosage Form Drug Market Dynamics
1.5.1 Solid Dosage Form Drug Market Drivers
1.5.2 Solid Dosage Form Drug Market Restraints
1.5.3 Solid Dosage Form Drug Industry Trends
1.5.4 Solid Dosage Form Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Solid Dosage Form Drug Revenue by Company (2018-2023)
2.2 Global Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Solid Dosage Form Drug Concentration Ratio
2.4 Global Solid Dosage Form Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Solid Dosage Form Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Solid Dosage Form Drug Revenue by Company (2018-2023)
3.2 China Solid Dosage Form Drug Solid Dosage Form Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Solid Dosage Form Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Solid Dosage Form Drug Industry Chain
4.2 Solid Dosage Form Drug Upstream Analysis
4.3 Solid Dosage Form Drug Midstream Analysis
4.4 Solid Dosage Form Drug Downstream Analysis
5 Sights by Type
5.1 Solid Dosage Form Drug Classification
5.1.1 Tablet
5.1.2 Capsules
5.1.3 Other
5.2 By Type, Global Solid Dosage Form Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Solid Dosage Form Drug Revenue, 2018-2029
6 Sights by Application
6.1 Solid Dosage Form Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Solid Dosage Form Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Solid Dosage Form Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Solid Dosage Form Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Solid Dosage Form Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Solid Dosage Form Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Solid Dosage Form Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Solid Dosage Form Drug Market Size Market Share
7.6 South America
7.6.1 South America Solid Dosage Form Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Solid Dosage Form Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Solid Dosage Form Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Solid Dosage Form Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Solid Dosage Form Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Solid Dosage Form Drug Market Size, 2018-2029
8.4.2 By Company, Europe Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Solid Dosage Form Drug Market Size, 2018-2029
8.5.2 By Company, China Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Solid Dosage Form Drug Market Size, 2018-2029
8.6.2 By Company, Japan Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Solid Dosage Form Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Solid Dosage Form Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Solid Dosage Form Drug Market Size, 2018-2029
8.9.2 By Company, India Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Solid Dosage Form Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.1.2 Johnson & Johnson Company Profile and Main Business
9.1.3 Johnson & Johnson Solid Dosage Form Drug Models, Specifications and Application
9.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.1.5 Johnson & Johnson Recent Developments
9.2 Novartis
9.2.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.2.2 Novartis Company Profile and Main Business
9.2.3 Novartis Solid Dosage Form Drug Models, Specifications and Application
9.2.4 Novartis Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.2.5 Novartis Recent Developments
9.3 Roche
9.3.1 Roche Company Information, Head Office, Market Area and Industry Position
9.3.2 Roche Company Profile and Main Business
9.3.3 Roche Solid Dosage Form Drug Models, Specifications and Application
9.3.4 Roche Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.3.5 Roche Recent Developments
9.4 AbbVie
9.4.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.4.2 AbbVie Company Profile and Main Business
9.4.3 AbbVie Solid Dosage Form Drug Models, Specifications and Application
9.4.4 AbbVie Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.4.5 AbbVie Recent Developments
9.5 Merck & Co.
9.5.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
9.5.2 Merck & Co. Company Profile and Main Business
9.5.3 Merck & Co. Solid Dosage Form Drug Models, Specifications and Application
9.5.4 Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.5.5 Merck & Co. Recent Developments
9.6 Bristol Myers Squibb
9.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
9.6.2 Bristol Myers Squibb Company Profile and Main Business
9.6.3 Bristol Myers Squibb Solid Dosage Form Drug Models, Specifications and Application
9.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.6.5 Bristol Myers Squibb Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.7.2 GlaxoSmithKline Company Profile and Main Business
9.7.3 GlaxoSmithKline Solid Dosage Form Drug Models, Specifications and Application
9.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.7.5 GlaxoSmithKline Recent Developments
9.8 Pfizer
9.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.8.2 Pfizer Company Profile and Main Business
9.8.3 Pfizer Solid Dosage Form Drug Models, Specifications and Application
9.8.4 Pfizer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.8.5 Pfizer Recent Developments
9.9 Sanofi
9.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.9.2 Sanofi Company Profile and Main Business
9.9.3 Sanofi Solid Dosage Form Drug Models, Specifications and Application
9.9.4 Sanofi Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.9.5 Sanofi Recent Developments
9.10 Takeda
9.10.1 Takeda Company Information, Head Office, Market Area and Industry Position
9.10.2 Takeda Company Profile and Main Business
9.10.3 Takeda Solid Dosage Form Drug Models, Specifications and Application
9.10.4 Takeda Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.10.5 Takeda Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.11.2 AstraZeneca Company Profile and Main Business
9.11.3 AstraZeneca Solid Dosage Form Drug Models, Specifications and Application
9.11.4 AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.11.5 AstraZeneca Recent Developments
9.12 Bayer
9.12.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.12.2 Bayer Company Profile and Main Business
9.12.3 Bayer Solid Dosage Form Drug Models, Specifications and Application
9.12.4 Bayer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.12.5 Bayer Recent Developments
9.13 Eli Lilly & Co.
9.13.1 Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position
9.13.2 Eli Lilly & Co. Company Profile and Main Business
9.13.3 Eli Lilly & Co. Solid Dosage Form Drug Models, Specifications and Application
9.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.13.5 Eli Lilly & Co. Recent Developments
9.14 Gilead Sciences
9.14.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position
9.14.2 Gilead Sciences Company Profile and Main Business
9.14.3 Gilead Sciences Solid Dosage Form Drug Models, Specifications and Application
9.14.4 Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.14.5 Gilead Sciences Recent Developments
9.15 Amgen
9.15.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.15.2 Amgen Company Profile and Main Business
9.15.3 Amgen Solid Dosage Form Drug Models, Specifications and Application
9.15.4 Amgen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.15.5 Amgen Recent Developments
9.16 Teva
9.16.1 Teva Company Information, Head Office, Market Area and Industry Position
9.16.2 Teva Company Profile and Main Business
9.16.3 Teva Solid Dosage Form Drug Models, Specifications and Application
9.16.4 Teva Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.16.5 Teva Recent Developments
9.17 Boehringer Ingelheim
9.17.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
9.17.2 Boehringer Ingelheim Company Profile and Main Business
9.17.3 Boehringer Ingelheim Solid Dosage Form Drug Models, Specifications and Application
9.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.17.5 Boehringer Ingelheim Recent Developments
9.18 Biogen
9.18.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.18.2 Biogen Company Profile and Main Business
9.18.3 Biogen Solid Dosage Form Drug Models, Specifications and Application
9.18.4 Biogen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.18.5 Biogen Recent Developments
9.19 Astellas
9.19.1 Astellas Company Information, Head Office, Market Area and Industry Position
9.19.2 Astellas Company Profile and Main Business
9.19.3 Astellas Solid Dosage Form Drug Models, Specifications and Application
9.19.4 Astellas Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
9.19.5 Astellas Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Solid Dosage Form Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Solid Dosage Form Drug Market Restraints
Table 3. Solid Dosage Form Drug Market Trends
Table 4. Solid Dosage Form Drug Industry Policy
Table 5. Global Solid Dosage Form Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Solid Dosage Form Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Solid Dosage Form Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Solid Dosage Form Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Solid Dosage Form Drug Manufacturers Product Type
Table 10. China Solid Dosage Form Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Solid Dosage Form Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Solid Dosage Form Drug Upstream (Raw Materials)
Table 13. Global Solid Dosage Form Drug Typical Customers
Table 14. Solid Dosage Form Drug Typical Distributors
Table 15. By Type, Global Solid Dosage Form Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Solid Dosage Form Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Solid Dosage Form Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Solid Dosage Form Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029
Table 22. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 23. Johnson & Johnson Company Profile and Main Business
Table 24. Johnson & Johnson Solid Dosage Form Drug Models, Specifications and Application
Table 25. Johnson & Johnson Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 26. Johnson & Johnson Recent Developments
Table 27. Novartis Company Information, Head Office, Market Area and Industry Position
Table 28. Novartis Company Profile and Main Business
Table 29. Novartis Solid Dosage Form Drug Models, Specifications and Application
Table 30. Novartis Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 31. Novartis Recent Developments
Table 32. Roche Company Information, Head Office, Market Area and Industry Position
Table 33. Roche Company Profile and Main Business
Table 34. Roche Solid Dosage Form Drug Models, Specifications and Application
Table 35. Roche Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 36. Roche Recent Developments
Table 37. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 38. AbbVie Company Profile and Main Business
Table 39. AbbVie Solid Dosage Form Drug Models, Specifications and Application
Table 40. AbbVie Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 41. AbbVie Recent Developments
Table 42. Merck & Co. Company Information, Head Office, Market Area and Industry Position
Table 43. Merck & Co. Company Profile and Main Business
Table 44. Merck & Co. Solid Dosage Form Drug Models, Specifications and Application
Table 45. Merck & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 46. Merck & Co. Recent Developments
Table 47. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 48. Bristol Myers Squibb Company Profile and Main Business
Table 49. Bristol Myers Squibb Solid Dosage Form Drug Models, Specifications and Application
Table 50. Bristol Myers Squibb Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 51. Bristol Myers Squibb Recent Developments
Table 52. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 53. GlaxoSmithKline Company Profile and Main Business
Table 54. GlaxoSmithKline Solid Dosage Form Drug Models, Specifications and Application
Table 55. GlaxoSmithKline Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 56. GlaxoSmithKline Recent Developments
Table 57. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 58. Pfizer Company Profile and Main Business
Table 59. Pfizer Solid Dosage Form Drug Models, Specifications and Application
Table 60. Pfizer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 61. Pfizer Recent Developments
Table 62. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 63. Sanofi Company Profile and Main Business
Table 64. Sanofi Solid Dosage Form Drug Models, Specifications and Application
Table 65. Sanofi Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 66. Sanofi Recent Developments
Table 67. Takeda Company Information, Head Office, Market Area and Industry Position
Table 68. Takeda Company Profile and Main Business
Table 69. Takeda Solid Dosage Form Drug Models, Specifications and Application
Table 70. Takeda Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 71. Takeda Recent Developments
Table 72. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 73. AstraZeneca Company Profile and Main Business
Table 74. AstraZeneca Solid Dosage Form Drug Models, Specifications and Application
Table 75. AstraZeneca Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 76. AstraZeneca Recent Developments
Table 77. Bayer Company Information, Head Office, Market Area and Industry Position
Table 78. Bayer Company Profile and Main Business
Table 79. Bayer Solid Dosage Form Drug Models, Specifications and Application
Table 80. Bayer Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 81. Bayer Recent Developments
Table 82. Eli Lilly & Co. Company Information, Head Office, Market Area and Industry Position
Table 83. Eli Lilly & Co. Company Profile and Main Business
Table 84. Eli Lilly & Co. Solid Dosage Form Drug Models, Specifications and Application
Table 85. Eli Lilly & Co. Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 86. Eli Lilly & Co. Recent Developments
Table 87. Gilead Sciences Company Information, Head Office, Market Area and Industry Position
Table 88. Gilead Sciences Company Profile and Main Business
Table 89. Gilead Sciences Solid Dosage Form Drug Models, Specifications and Application
Table 90. Gilead Sciences Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 91. Gilead Sciences Recent Developments
Table 92. Amgen Company Information, Head Office, Market Area and Industry Position
Table 93. Amgen Company Profile and Main Business
Table 94. Amgen Solid Dosage Form Drug Models, Specifications and Application
Table 95. Amgen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 96. Amgen Recent Developments
Table 97. Teva Company Information, Head Office, Market Area and Industry Position
Table 98. Teva Company Profile and Main Business
Table 99. Teva Solid Dosage Form Drug Models, Specifications and Application
Table 100. Teva Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 101. Teva Recent Developments
Table 102. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
Table 103. Boehringer Ingelheim Company Profile and Main Business
Table 104. Boehringer Ingelheim Solid Dosage Form Drug Models, Specifications and Application
Table 105. Boehringer Ingelheim Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 106. Boehringer Ingelheim Recent Developments
Table 107. Biogen Company Information, Head Office, Market Area and Industry Position
Table 108. Biogen Company Profile and Main Business
Table 109. Biogen Solid Dosage Form Drug Models, Specifications and Application
Table 110. Biogen Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 111. Biogen Recent Developments
Table 112. Astellas Company Information, Head Office, Market Area and Industry Position
Table 113. Astellas Company Profile and Main Business
Table 114. Astellas Solid Dosage Form Drug Models, Specifications and Application
Table 115. Astellas Solid Dosage Form Drug Revenue and Gross Margin, 2018-2023
Table 116. Astellas Recent Developments
List of Figure
Figure 1. Solid Dosage Form Drug Picture
Figure 2. Global Solid Dosage Form Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Solid Dosage Form Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Solid Dosage Form Drug Market Share of Global
Figure 5. Global Solid Dosage Form Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Solid Dosage Form Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Solid Dosage Form Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Solid Dosage Form Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Solid Dosage Form Drug Industry Chain
Figure 10. Tablet
Figure 11. Capsules
Figure 12. Other
Figure 13. By Type, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Retail Pharmacy
Figure 17. Other
Figure 18. By Application, Global Solid Dosage Form Drug Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029
Figure 20. By Region, Global Solid Dosage Form Drug Revenue Market Share, 2018-2029
Figure 21. North America Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Solid Dosage Form Drug Revenue Market Share, 2018-2023
Figure 23. Europe Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Solid Dosage Form Drug Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Solid Dosage Form Drug Revenue Market Share, 2018-2023
Figure 27. South America Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Solid Dosage Form Drug Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Solid Dosage Form Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Solid Dosage Form Drug Market Share, 2018-2023
Figure 32. By Type, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 34. Europe Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Solid Dosage Form Drug Market Share, 2018-2023
Figure 36. By Type, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 38. China Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Solid Dosage Form Drug Market Share, 2018-2023
Figure 40. By Type, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 42. Japan Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Solid Dosage Form Drug Market Share, 2018-2023
Figure 44. By Type, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Solid Dosage Form Drug Market Share, 2018-2023
Figure 48. By Type, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Solid Dosage Form Drug Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 54. India Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Solid Dosage Form Drug Market Share, 2018-2023
Figure 56. By Type, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Solid Dosage Form Drug Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Solid Dosage Form Drug Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Solid Dosage Form Drug Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Research Methodology:
Solid Dosage Form Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|